Mitchell P. Kopin 13D and 13G filings for Silexion Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 4:49 pm Purchase | 2025-12-31 | 13G | SILEXION THERAPEUTICS CORP SLXN | Mitchell P. Kopin | 32,500 9.400% | 8,023 (+32.78%) | Filing |
| 2025-09-17 5:14 pm Purchase | 2025-09-11 | 13G | SILEXION THERAPEUTICS CORP SLXN | Mitchell P. Kopin | 24,477 9.990% | 23,078 (+1649.61%) | Filing |